Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, NDC 61958-2901-2

FDA recall notice · announced October 9, 2024 · Gilead Sciences

Class I FDA/FSIS Class I: reasonable probability that use will cause serious adverse health consequences or death.

The product

Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, NDC 61958-2901-2

Reason for recall

Presence of Particulate Matter: Presence of glass particle.

Notes

Distribution: Nationwide in the U.S.A.
Lot/code information: Lot: 47035CFA, Exp. 11/2025
Quantity: 105,000 vials
Status: Terminated
Products in this recall event:
- Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, NDC 61958-2901-2 (D-0005-2025)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.